We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Agios Pharmaceuticals
AGIO
$2.04B
| $9.4M | 0.01% |
310,781
-43,674
| -12% | -$1.45M |
|
677
Avery Dennison
AVY
$13.7B
| $9.38M | 0.01% |
52,689
+723
| +1% | +$133K |
|
678
Carvana
CVNA
$79.7B
| $9.29M | 0.01% |
222,360
+2,760
| +1% | +$122K |
|
679
Tyson Foods
TSN
$19.6B
| $9.27M | 0.01% |
145,311
+3,962
| +3% | +$233K |
|
680
Dollar Tree
DLTR
$24.7B
| $9.24M | 0.01% |
123,092
+14,376
| +13% | +$1.03M |
|
681
Chemed
CHE
$7.07B
| $9.22M | 0.01% |
14,983
-14,558
| -49% | -$8.27M |
|
682
Booz Allen Hamilton
BAH
$9.43B
| $9.22M | 0.01% |
88,146
+35,312
| +67% | +$4.26M |
|
683
Estee Lauder
EL
$31.7B
| $9.12M | 0.01% |
138,210
-178,282
| -56% | -$12.9M |
|
684
Kanzhun
BZ
$7.19B
| $9.07M | 0.01% |
473,171
+28,419
| +6% | +$463K |
|
685
CRISPR Therapeutics
CRSP
$5.22B
| $9.07M | 0.01% |
246,086
-26,618
| -10% | -$1.13M |
|
686
Ball Corp
BALL
$16.4B
| $9.04M | 0.01% |
173,574
-2,823
| -2% | -$148K |
|
687
Petrobras
PBR
$114B
| $9.02M | 0.01% |
628,706
-414,123
| -40% | -$5.71M |
|
688
Grab
GRAB
$14.7B
| $9.02M | 0.01% |
1,990,116
+305,248
| +18% | +$1.42M |
|
689
Everest Group
EG
$13.9B
| $9M | 0.01% |
24,776
+1,174
| +5% | +$415K |
|
|
WBA
690
DELISTED
Walgreens Boots Alliance
WBA
| $8.97M | 0.01% |
802,847
+320,821
| +67% | +$3.48M |
|
691
Rocket Pharmaceuticals
RCKT
$374M
| $8.79M | 0.01% |
1,317,969
| – | – |
|
|
CTRA
692
DELISTED
Coterra Energy
CTRA
| $8.67M | 0.01% |
299,914
-797
| -0.3% | -$22.2K |
|
693
iShares Global Infrastructure ETF
IGF
$10.7B
| $8.62M | 0.01% |
158,300
+12,800
| +9% | +$687K |
|
694
FirstEnergy
FE
$27.2B
| $8.59M | 0.01% |
212,406
-4,747
| -2% | -$189K |
|
695
Kinross Gold
KGC
$32.6B
| $8.58M | 0.01% |
681,160
+27,965
| +4% | +$314K |
|
696
Western Digital
WDC
$157B
| $8.51M | 0.01% |
210,381
-57,542
| -21% | -$2.73M |
|
697
Carnival Corporation Ltd
CCL
$37.9B
| $8.49M | 0.01% |
434,490
+12,387
| +3% | +$295K |
|
698
Huazhu Hotels Group
HTHT
$12.7B
| $8.37M | 0.01% |
226,162
+12,200
| +6% | +$422K |
|
699
Leidos
LDOS
$17.6B
| $8.35M | 0.01% |
61,890
-3,562
| -5% | -$497K |
|
|
JNPR
700
DELISTED
Juniper Networks
JNPR
| $8.31M | 0.01% |
229,533
+16,865
| +8% | +$617K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.